Loading chart...
PODDPODD
$140.66In ribasso 0.63 percento, −$0.90
Il Sep 18 alle 3:59 PM ET
Statistiche chiave
Capitalizzazione di Mercato$9.751B
Volume (24h)1,140,640
Day's Range$139.82-$142.25
52-Week Range$126.40-$354.88
PE Ratio102.67
EPS1.37
Net Income (FY)$247.10M
Revenue (FY)$2.71B
Chi Siamo Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
- Sito web
- insulet.com
- Settore
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Dipendenti a tempo pieno
- 5400
- Sede
- ACTON
- Data IPO
- May 15, 2007
| 24 ore | 5 days | 1 mese | YTD | 1 anno | Sempre |
|---|---|---|---|---|---|
In ribasso 0.63 percento | In rialzo 2.07 percento | In ribasso 7.16 percento | In ribasso 51.00 percento | In ribasso 57.49 percento | In rialzo 781.30 percento |
